Kevin Heal

Stock Analyst at Argus Research

(3.21)
# 961
Out of 4,829 analysts
48
Total ratings
65.62%
Success rate
7.4%
Average return

Stocks Rated by Kevin Heal

Celestica
Apr 29, 2025
Maintains: Buy
Price Target: $150$120
Current: $93.05
Upside: +28.96%
AGNC Investment
Apr 29, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.79
Upside: -
Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76$82
Current: $79.21
Upside: +3.52%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $21.16
Upside: +22.87%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $46.51
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15$16
Current: $15.22
Upside: +5.12%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77$80
Current: $77.85
Upside: +2.76%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $178.33
Upside: -14.20%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440$460
Current: $492.18
Upside: -6.54%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36$39
Current: $39.12
Upside: -0.31%
Maintains: Buy
Price Target: $225$245
Current: $284.35
Upside: -13.84%
Maintains: Buy
Price Target: $11$12
Current: $11.23
Upside: +6.86%
Downgrades: Hold
Price Target: n/a
Current: $55.98
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $231.71
Upside: -
Upgrades: Hold
Price Target: n/a
Current: $11.11
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $19.23
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $4.23
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $202.64
Upside: -
Upgrades: Buy
Price Target: $185
Current: $289.88
Upside: -36.18%